EE9900176A - Helicobacter pylori'ga seotud nukleiinhapete ja aminohapete järjestused ning nende vaktsiinikompositsioonid - Google Patents

Helicobacter pylori'ga seotud nukleiinhapete ja aminohapete järjestused ning nende vaktsiinikompositsioonid

Info

Publication number
EE9900176A
EE9900176A EEP199900176A EE9900176A EE9900176A EE 9900176 A EE9900176 A EE 9900176A EE P199900176 A EEP199900176 A EE P199900176A EE 9900176 A EE9900176 A EE 9900176A EE 9900176 A EE9900176 A EE 9900176A
Authority
EE
Estonia
Prior art keywords
nucleic
amino acid
acid sequences
helicobacter pylori
vaccine compositions
Prior art date
Application number
EEP199900176A
Other languages
English (en)
Inventor
Smith Douglas
A. Alm Richard
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9900176A publication Critical patent/EE9900176A/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP199900176A 1996-10-28 1997-10-28 Helicobacter pylori'ga seotud nukleiinhapete ja aminohapete järjestused ning nende vaktsiinikompositsioonid EE9900176A (et)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US73915096A 1996-10-28 1996-10-28
US75973996A 1996-12-06 1996-12-06
US89192897A 1997-07-14 1997-07-14
PCT/US1997/019575 WO1998018323A1 (en) 1996-10-28 1997-10-28 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof

Publications (1)

Publication Number Publication Date
EE9900176A true EE9900176A (et) 1999-12-15

Family

ID=27419246

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900176A EE9900176A (et) 1996-10-28 1997-10-28 Helicobacter pylori'ga seotud nukleiinhapete ja aminohapete järjestused ning nende vaktsiinikompositsioonid

Country Status (19)

Country Link
EP (1) EP0973394A4 (et)
JP (1) JP2001504329A (et)
KR (1) KR20000052831A (et)
CN (1) CN1235513A (et)
AR (1) AR009600A1 (et)
AU (1) AU734052B2 (et)
BR (1) BR9712587A (et)
CA (1) CA2265523A1 (et)
EE (1) EE9900176A (et)
ID (1) ID22065A (et)
IL (1) IL129397A0 (et)
IS (1) IS5005A (et)
NO (1) NO991995L (et)
NZ (1) NZ334568A (et)
PL (1) PL333169A1 (et)
SA (1) SA98180918A (et)
SK (1) SK34699A3 (et)
TR (1) TR199900940T2 (et)
WO (1) WO1998018323A1 (et)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406703B1 (en) 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
US5871749A (en) * 1993-07-27 1999-02-16 Csl Limited Therapeutic treatment of H. pylori associated gastroduodenal disease
DE19730425A1 (de) 1997-07-16 1999-01-21 Henkel Teroson Gmbh Heißhärtende wäschefeste Rohbau-Versiegelung
WO2000006743A2 (en) * 1998-07-27 2000-02-10 Connaught Laboratories Limited Chlamydia antigens and corresponding dna fragments and uses thereof
SE9901548D0 (sv) * 1999-04-29 1999-04-29 Astra Ab Helicobacter pylori antigens
GB9914945D0 (en) * 1999-06-25 1999-08-25 Smithkline Beecham Biolog Novel compounds
AUPQ347199A0 (en) * 1999-10-15 1999-11-11 Csl Limited Novel polypeptide fragments
JP5571274B2 (ja) 2000-03-08 2014-08-13 ノボザイムス アクティーゼルスカブ 改変された特性を有する変異体
GB0010370D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
GB0010371D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
JP6078865B2 (ja) * 2011-03-17 2017-02-15 国立大学法人三重大学 抗体の製造方法
US10828358B2 (en) * 2015-12-14 2020-11-10 Technische Universität München Helicobacter pylori vaccines
CN115724922B (zh) * 2022-07-19 2023-08-22 四川大学华西医院 一种幽门螺杆菌疫苗重组蛋白抗原TonB及其制备方法与应用
CN115581201A (zh) * 2022-08-26 2023-01-10 云南省农业科学院花卉研究所 以茎段为外植体诱导的二倍体月季f1-61的植株再生方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9300139L (sv) * 1993-01-19 1994-07-20 Medicarb Ab Framställning av ett nytt läkemedel

Also Published As

Publication number Publication date
SA98180918A (ar) 2005-12-03
NZ334568A (en) 2000-04-28
NO991995L (no) 1999-06-28
EP0973394A4 (en) 2005-03-30
KR20000052831A (ko) 2000-08-25
ID22065A (id) 1999-08-26
IS5005A (is) 1999-03-18
BR9712587A (pt) 1999-10-26
CA2265523A1 (en) 1998-05-07
NO991995D0 (no) 1999-04-27
WO1998018323A1 (en) 1998-05-07
IL129397A0 (en) 2000-02-17
AR009600A1 (es) 2000-04-26
JP2001504329A (ja) 2001-04-03
PL333169A1 (en) 1999-11-22
CN1235513A (zh) 1999-11-17
SK34699A3 (en) 2000-04-10
AU734052B2 (en) 2001-05-31
TR199900940T2 (xx) 1999-09-21
EP0973394A1 (en) 2000-01-26
AU5093398A (en) 1998-05-22

Similar Documents

Publication Publication Date Title
EE9900176A (et) Helicobacter pylori'ga seotud nukleiinhapete ja aminohapete järjestused ning nende vaktsiinikompositsioonid
EE9800334A (et) Helicobacter pylor' iga seotud nukleiinhapete ja aminohapete järjestused ja nendest tuletatud vaktsiinikompositsioonid
EE9900226A (et) Helicobacter pylori'ga seotud nukleiinhapete ja aminohapete järjestused ning nende vaktsiinikompositsioonid
NO975490L (no) Heliobacter pylori antigener og vaksinesammensetninger
PT1114644E (pt) Composicao compreendendo insulina e factor-i de crescimento do tipo insulina (igf-i)
PL344589A1 (en) COMPOSITION COMPRISING β-HYDROXY-β-METHYLBUTYRIC ACID AND AT LEAST ONE AMINO ACID AND METHODS OF USE
EP1015470A4 (en) COMPOSITION AND METHOD FOR DELIVERING NUCLEIC ACIDS
DE59711379D1 (de) Oral applizierbare formulierungen von chinolon- oder naphthyridoncarbonsäuren
EE200200312A (et) Uued Helicobacter pylori'ga seonduvad ained ja nende kasutamine
DE69821053T2 (de) Verfahren zur Herstellung von 2,2,6,6-Tetramethyl-4-piperidyl-Gruppen enthaltenden Polytriazinen
IL125933A0 (en) Canine ob protein compositions and methods
ZA9710971B (en) Nucleic acid and amino acid sequences relating to Helicobacter pylori and vaccine compositions thereof.
ZA972715B (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof.
ZA979672B (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine composition thereof
HK1017385A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
HK1024597A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
HK1024176A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
HUP0000521A3 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
HUP9903843A3 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
EE9900566A (et) Helicobacter pylori FlgE polüpeptiidi sisaldavad vaktsiinikoostised
EE9700373A (et) Helicobacter pyloriga seotud nukleiinhapete ja aminohapete järjestused diagnoosimiseks ja raviks
RU99111594A (ru) Нуклеиново-кислотные и аминокислотные последовательности helicobacter pylori, и их вакцинные композиции
RU99114027A (ru) Нуклеиново-кислотные и аминокислотные последовательности helicobacter pylory и их вакцинные композиции
SE9702428D0 (sv) GAs composition
AU7537598A (en) Dna based anti-(helicobacter) vaccine composition